Search - tctmd.com

Displaying 1 - 20 of 162

Sort: Relevancy | Date

News Opinion CV Team Dispatch

January 2026 Dispatch for the CV Team

L.A. McKeown

January 16, 2026

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

Year in Review: Top Prevention Stories of 2025

Michael O'Riordan

December 24, 2025

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Daily News

Cardiac Damage Starts Early When There’s Family History of Cardiometabolic Disease

Caitlin E. Cox

December 18, 2025

News Daily News

Healthcare Expenses Increase After GLP-1 Prescription

L.A. McKeown

August 18, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Daily News

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Caitlin E. Cox

February 26, 2025

News Daily News

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

L.A. McKeown

January 10, 2025

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Daily News

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Todd Neale

November 13, 2024

News Features

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Michael O'Riordan

October 21, 2024

News Daily News

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

Michael O'Riordan

October 03, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Daily News

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Michael O'Riordan

August 21, 2024

Advertisement

January 2026 Dispatch for the CV Team

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Year in Review: Top Prevention Stories of 2025

December 2025 Dispatch for the CV Team

Cardiac Damage Starts Early When There’s Family History of Cardiometabolic Disease

Healthcare Expenses Increase After GLP-1 Prescription

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

April 2025 Dispatch for the CV Team

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

March 2025 Dispatch for the CV Team

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

Top General Cardiology and Prevention News of 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content